Sugi Predict

Sugi Predict / Compounds / SCHEMBL7535256

SCHEMBL7535256

SCHEMBL7535256

CCCCCCCCCCCC(=O)O[Sn](CCC)(CCC)CCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DGKA P23743 1/20 0.53
▸ LMNA P02545 2/20 0.50
▸ PAM P19021 2/20 0.48
▸ MAPT P10636 2/20 0.47
▸ MAPK1 P28482 1/20 0.47
▸ CES2 O00748 3/20 0.46
▸ CES1 P23141 3/20 0.46
▸ TSHR P16473 5/20 0.46
▸ PPARG P37231 6/20 0.45
▸ PPARD Q03181 6/20 0.45
▸ PPARA Q07869 6/20 0.45
▸ HDAC11 Q96DB2 5/20 0.45
▸ GPR84 Q9NQS5 4/20 0.45
▸ ALDH1A1 P00352 2/20 0.45
▸ TLR2 O60603 2/20 0.45
▸ TDP1 Q9NUW8 2/20 0.45
▸ FABP4 P15090 2/20 0.45
▸ PTPN1 P18031 2/20 0.45
▸ SLC22A6 Q4U2R8 1/20 0.45
▸ SLC22A8 Q8TCC7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5108551 0.92 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL673495 0.92 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL2695213 0.92 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL8401967 0.92 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL10479944 0.92 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL394258 0.92 DGKA (0.53) DGKALMNAPAMMAPTMAPK1
SCHEMBL10558076 0.90 DGKA (0.52) DGKALMNAPAMMAPTMAPK1
SCHEMBL11763643 0.90 TERT (0.54) DGKALMNAMAPTPPARGPPARD
SCHEMBL2569827 0.88 DGKA (0.47) DGKALMNAPAMMAPTMAPK1
SCHEMBL10556582 0.86 LMNA (0.57) DGKALMNAPAMMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3034547-B1 A process for the preparation of a block copolymer comprising a first polyolefin block and a second polymer block SABIC GLOBAL TECHNOLOGIES BV (NL) 2019-10-09 — — EP claimed
EP-3034547-A1 A process for the preparation of a block copolymer comprising a first polyolefin block and a second polymer block and the products obtained therefrom SABIC Global Technologies B.V. (NL) 2016-06-22 — — EP claimed
EP-3577171-B1 AQUEOUS SYSTEM FOR FORMING A COATING ON A SUBSTRATE BASF SE (DE) 2020-11-18 — — EP disclosed
US-10815383-B2 Pigmented primer composition for forming an n-acyl urea coating BASF SE (DE) 2020-10-27 — — US disclosed
EP-3328945-B1 PIGMENTED PRIMER COMPOSITION FOR FORMING AN N-ACYL UREA COATING BASF SE (DE) 2019-10-30 — — EP disclosed
US-10457767-B2 Method of preparing a polycarbodiimide polymer and polycarbodiimide polymer prepared thereby BASF SE (DE) 2019-10-29 — — US disclosed
US-10435499-B2 Solvent-borne system for forming an n-acyl urea coating BASF SE (DE) 2019-10-08 — — US disclosed
EP-2751154-B1 HIGH MOLECULAR WEIGHT POLYCARBODIIMIDE AND METHOD OF PRODUCING SAME BASF SE (DE) 2019-08-21 — — EP disclosed
EP-3105275-B1 METHOD OF PREPARING A POLYCARBODIIMIDE POLYMER AND POLYCARBODIIMIDE POLYMER PREPARED THEREBY BASF SE (DE) 2019-01-09 — — EP disclosed
US-20180298557-A1 METHODS FOR TREATING PAPERBOARDS AND PAPER MEDIA, AND ASSOCIATED TREATED PAPERBOARDS AND PAPER MEDIA BASF CORPORATION 2018-10-18 — — US disclosed
US-20180223111-A1 PIGMENTED PRIMER COMPOSITION FOR FORMING AN N-ACYL UREA COATING BASF CORPORATION 2018-08-09 — — US disclosed
WO-2012104190-A1 A PROPPANT BASF SE (DE) 2012-08-09 — — WO disclosed
US-20020197732-A1 Method and apparatus for combinatorial screening of polymer compositions GENERAL ELECTRIC COMPANY 2002-12-26 — — US disclosed
US-6489503-B1 COMPOSITION COMPRISING METHYLENE BIS(PHENYLISOCYANATE) COMPONENT AND POSITIVE AMOUNT OF URETONIMINE, WHICH IS STORAGE STABLE AS LIQUID AT TEMPERATURE OF AT LEAST 30 DEGREES C. BASF CORPORATION 2002-12-03 — — US disclosed
US-6120699-A CONVERTING A PORTION OF THE 4,4'-MDI INTO A POSITIVE AMOUNT OF A CARBODIIMIDE, THE CARBODIIMIDE SUBSEQUENTLY BEING CONVERTED INTO A POSITIVE AMOUNT OF A URETONIMINE IN THE PRESENCE OF EXCESS 4,4'-MDI BASF CORPORATION (US) 2000-09-19 — — US disclosed
EP-0989116-A1 Storage stable methylene bis(phenylisocyanate) compositions Basf Corporation (US) 2000-03-29 — — EP disclosed
US-4424288-A Carbodiimide-modified polymethylene polyphenylene polyisocyanates for use in the preparation of polyisocyanurate-polyurethane foams BASF WYANDOTTE CORPORATION (US) 1984-01-03 — — US disclosed
US-4284730-A Liquid carbodiimide- and uretonimine-isocyanurate-containing polyisocyanate compositions and microcellular foams made therefrom BASF WYANDOTTE CORPORATION (US) 1981-08-18 — — US disclosed
US-4228095-A Process for the preparation of liquid carbodiimide-modified organic polyisocyanates employing organotin catalysts BASF WYANDOTTE CORPORATION (US) 1980-10-14 — — US disclosed
US-4018708-A TRANSESTERIFICATION CATALYSTS BASF WYANDOTTE CORPORATION (US) 1977-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10457767-B2 Method of preparing a polycarbodiimide polymer and polycarbodiimide polymer prepared thereby PAICS, PBRM1, PARG DGKA 1336/4885LMNA 2029/4885PAM 220/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.